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Context: Helicobacter pylori is the most common infecting organism affecting humans, being almost half the population infected. The aim of this study was to find out the epidemiological features and the sensitivity of diagnostic methods of Helicobacter pylori infection in Iran, which can provide the logic of developing preventive approaches to control Helicobacter pylori infections and the associated diseases.
Evidence Acquisition: By reviewing the databases of SID, MAGIRAN, SCOPUS, MEDLIB, Google, ISI and PUBMED, a total of 30 papers, published from 1994 to 2011, were extracted. Summary prevalence and 95% confidence intervals (95% CI) were calculated using random-effects model. Statistical analyses were performed using STATA Ver.11.
Results: Among the 30 studies evaluated, the prevalence rate of Helicobacter pylori infections in Iran was estimated as 50.7 % (95% CI: 44.4-56.9%). When the sensitivity of diagnostic methods was evaluated, ELISA, with an accuracy rate of 52.3% (95% CI: 43.8 to 60.8%) was found the most accurate diagnostic method available. The highest and the least Helicobacter pylori prevalence were 19.2% in Tehran and 74.27% in Mazandran respectively.
Conclusions: About half the population in Iran is infected with Helicobacter pylori, the pollution in different areas and preventive strategies should be carried out to control this infection. The prevalence rate of Helicobacter pylori infections in Iran showed only little changes during the years 1994 to 2011.
Keywords:Helicobacter pylori; Prevalence; Meta-analysis; Iran
Implication for health policy/practice/research/medical education:This is the first systematic review and meta-analysis on prevalence of H. pylori in Iran that prepared in collaboration with Dr. Raffaele Zarrilli in Italy. In this review, we used nearly all of the papers published in Persian and English languages.Copyright © 2014, Iranian Red Crescent Medical Journal; Published by Kowsar Corp. This is an open-access article distributed under the terms of the Creative Com-mons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. ContextAlmost half the population in the world is infected by H. pylori which is the most common infecting organism affecting humans (1, 2). Since the first experience of Heli-cobacter culture in 2004 by Marshall and Warren, a con-siderable amount of information has been acquired on clinical aspects of this infection (3). Helicobacter pylori is tightly associated with gastro-intestinal disorders, some important consequences of which can be chronic gastri-tis, peptic ulcer leading to gastric cancer, indigestion and non-ulcer dyspepsia (4-9).In developing countries, the prevalence of H. pylori positive serology during childhood is higher than that in developed countries. This is vice versa during adult-hood (10, 11). In a Meta-analysis study, the prevalence of H. pylori infection in China was reported as 58.07% (12). In another Meta-analysis study, the association between H. pylori infection and the risk of esophageal cancer (EAC) has been suggested (13). Also, the association between H. 
pylori infection in diabetic and non-diabetic individuals with dyspepsia was assessed. This study showed that the prevalence of H. pylori infection was considerably higher in diabetic patients compared to non-diabetic individu-als (P = 0.001). According to these results, diabetes Mel-litus is one of the risk factors that need attention in the evaluation of H. pylori infections among diabetic patients with dyspepsia (14).The prevalence of H. pylori infection was 58% among residents of two villages in Northern Italy, considerably higher than the 34% observed in an earlier similar study of adults in northern Swedish communities (mean age = 52 years). A prevalence of 60% or more was reported for groups in Albania, Egypt, Iran, Turkey, and China (15). The prevalence of H. pylori infection was 3.0% among index children at age 4 and maternal infection was the only risk factor at multivariate analysis (16).One of the main objectives of Meta-analysis studies, 
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which are a combination of different studies, is to reduce the difference between parameters as a result of an in-crease in the number of studies involved in the process of analysis and also to reduce the confidence level of these measures/figures.The aim of this study was to investigate the studies car-ried out on the prevalence of H. pylori infection in Iran and to estimate the prevalence rate of this infection according to diagnostic methods, age group of individuals infected, gender, infection age and additional parameters.
2. Evidence AcquisitionThis study was a systematic review and a Meta-analysis study on the prevalence of Helicobacter in Iran. The find-ings of this research were based on the papers published in internal and external journals. The papers were selected from the databases of SID, MAGIRAN, SCOPUS, MEDLIB, Google, ISI and PUBMED. Searching of the articles was car-ried out using the key words: Helicobacter, prevalence, and a combination of these words. To decrease bias two authors (Sayehmiri F, Darvishi Z) did search, selection of papers and extracting data of articles independently. First, all the ar-ticles related to Helicobacter pylori in Iran were collected. At this stage, the articles possessing the relevant key words in their title or abstract were entered into the list, exclud-ing all the other articles not relevant to the prevalence of H. pylori. A check list of necessary information was prepared that included: title of the article, location of the study, loca-tion of sampling, sample volume, the methods of assessing infection, the mean age of individuals infected by H. pylori and the total prevalence of H. pylori.According to the protocol, a total of 142 articles that were carried out from 1994 to 2011 were analyzed during the pri-mary research. The abstracts of 94 articles, out of the 142, were then analyzed and a complete review of 45 of these papers, that included the basic information required, was then carried out. Due to unavailability of the prevalence rates, some articles were omitted and a total of 30 articles were finally entered into the process of analysis (17-46) (Fig-ure 1 the study flowchart).
2.1. Statistical AnalysisThe variance of each study was calculated according to the binomial distribution. The studies were com-bined together according to sample size and variance. Because of the study heterogeneity, random-effect model was used to combine the studies. To assess the heterogeneity of the studies, Cochrane Q test and the I2 index were used. P-value of less than 5% was considered as significant in the heterogeneity test. To investigate the relationship between years of study and sample size meta-regression model was used.Furthermore, considering the type of data analyzed, which were all prevalence rates, there was no need to determine the publication bias and to draw a funnel plot. The data were analyzed using STATA version 11.2.
3. ResultsIn the 30 papers assessed, the prevalence rate of Helico-bacter pylori infection in Iran was estimated as 50.7% (95% CI: 44.4-56.9%) (Figure 2). The lowest prevalence rate (19.2%) was related to a study in Mazandaran province, the city of Sari and the highest prevalence rate (74.27%) were reported in a study in Tehran province, the city of Tehran. Details of the papers analyzed are found in Table 1.In one classification, analysis was carried out based on the diagnostic methods. The sensitivity level of ELISA, ac-cording to this analysis, was estimated as 52.3% (95% CI: 43.8-60.8), the sensitivity of the urease method as 51.9% (95% CI: 36.9-66.9) and other diagnostic methods including touch cytology, histopathology as 45.8% (95% CI: 31.3-60.4). These results show that ELISA and urease are relatively more ac-curate methods to diagnose H. pylori infection (Table 2).In another classification, the individuals under assay were divided into the two groups of symptomatic and non-symptomatic individuals. The prevalence rate of infection among individuals with digestive disease symptoms, with a sample size of 1873 individuals, was estimated as 47.6% (95% CI: 56.1-39.2) and among healthy individuals, with a sample size of 7131 individuals, as 53.1% (95% CI: 45.4-60.8). Based on gender, the prevalence rate was estimated as 37.7% (95% CI: 95% CI: 27.5-48) in females and 35.7% (95% CI: 19.6-51.7) in males. In analysis based on the age groups, the prevalence rate among the age group below 20 years was estimated as 38.3% (95% CI: 28.1-48.5), among the age group between 20-40 years as 50.3 % (95% CI: 39.5-61) and among the age group above 40 as 60.1% (95% CI: 52.4-67.8). In this analysis, a sig-nificant difference was found among the three age groups which can be evidence to the conclusion that the rate of H. pylori infection increases as the age increases (Table 3).
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Figure 1. Study Flowchart
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Figure 2. The Prevalence Rate of H. pylori Infection and its 95% Confidence Interval
According to the year and the location of studies assessed. The midpoint of each line illustrates the prevalence rate estimated in each study. The diamond sign shows the prevalence rate throughout the country for all the studies.
The Figure 3 shows the relationship between the preva-lence of H. pylori infection and year of study, and sample size using meta regression models. In Figure 3 A the nega-tive slope of the meta regression line showed that the prevalence of H. pylori infection in Iran has had a decreas-ing trend with a slow slop but it was not significant. In Fig-ure 3 B the relation between sample size was compared to 
the prevalence rate of H. pylori infection and according to this figure there isn’t a significant relation between the sample size and prevalence (P = 0.06). At the following figure the circles show the weight of studies and it seems that studies with greater sample sizes are more prevalent and vice versa (Figure 3). In the Table 4, a summary of data related to meta-regression curves are shown.
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Table 1.  Summary of Included Studies Evaluating the Prevalence Rate of H. pylori in Iran
City year Age,y Sample 
Size
Diagnostic 
Method
Prevalence 95% CI References
Kashan 2000 4.1 ± 9.9 39 Urease 30.8 45.3 16.3 Taghavi et al. (30)
Sari 2000 7-18 400 - 19.2 23.1 15.3 Tergar Fakheri et al. (39)
Semnan 1999 700 Elisa 48 57.1 44.3 Moradi et al . (22)
Ghazvin 2002 54.4 125 Urease 43.7 52.4 35 Hajagamohammadi et al. (17)
Sari 2001 394 Elisa 64.2 69.1 59.7 Baba mahmoodi et al. (38)
Khorasan 
razavi
2004 12-75 195 Urease 62.56 69.4 55.8 Nakhaei Moghadam et al. (40)
Tehran 2002 30.65 120 Urease 68.3 76.6 60 Faghihi et al. (23)
Yazd 2004 30-65 28 - 43.5 61.9 25.1 Benesh et al. (41)
Ghazvin 2002 10-60 240 Elisa 2000.5 86.7 1993.3 Sheikholslami et al. (18)
Tabriz 2009 3.21 ± 8.38 116 Serology Children 60.3, Moth-ers 57.8, Fathers 37.9 61.1 42.9 Rafiei et al. (31)
Kerman 1993 57.05 513 Urease 56.9 61.2 52.6 Zojajy (19)
Tehran 2002 8.8 ± 48 576 Endoscopy 59.7 63.7 55.7 Yasseri (24)
Tehran 2004 2.2 ± 24 137 Elisa 65.57 75.3 56.7 Sharifian et al. (32)
Tehran 2004-2006 6-12 1665 Urease 26 28.1 23.9 Zamani et al. (25)
Tehran 2003 - 170 Histopathology 29.4 36.2 22.6 Barati et al. (26)
Tabriz - - 120 - 71.6 2000.7 63.5 Rahnama et al. (43)
Tabriz - - 86 - 42.6 53.1 32.1 Rafeey et al. (44)
Tabriz 2003 0.03 ± 8.3 96 - 64.6 74.2 55 Modaresi et al. (45)
Kurdistan 2006 14.91 ± 15.32 1503 Elisa 36.5 38.9 34.1 Yazdanpanah et al. (33)
Tehran 2006 39 152 - 35.52 43.1 27.9 Shokohizadeh et al. (46)
Tehran 2010 43.9 311 - 74.27 2000.1 69.4 Neshandar et al. (34)
Kashan 2007 17.13 ± 43.3 100 Elisa 66 75.3 56.7 Arj et al. (20)
Tehran 2003 11.67 ± 39.68 50 Urease, IgG, Histology 70 2003.7 57.3 Baghaei et al. (42)
Isfahan 2010 16-62 100 PCR 30 39 21 Salehi et al. (27)
Guilan 2004 11.30 ± 32.38 50 Elisa 54 67.8 40.2 Ghanei et al. (28)
Tehran 2001 100 Urease, Pathol-ogy 57 66.7 47.3 Gottaslou et al. (29)
Guilan 2005 7-11 961 Elisa 40 43.1 36.9 Mansor et al. (35)
Tehran 2001 48.3 1993 Citology 58.3 69.7 46.9 Vahidi et al. (36)
Isfahan 2002 70 Elisa 44.44 56.1 32.8 Sanei et al. (21)
Khorasan 
razavi
2006 4.77 ± 23.50 187 Elisa 34.7 41.5 27.9 Dolatian et al. (37)
- - - - - 50.7 56.9 44.4 -
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To assess publication bias we used funnel plot (Figure 4) that it showed there was a significant publication bias (P = 0.016). In another classification, the analysis was car-ried out based on the city of the study, according to which the highest prevalence rate (61.7%), with a sample size of 245 individuals, was related to Ghazvin province (95% CI: 26.6-96.8) and the lowest prevalence rate (36.5%), with a sample size of 73 individuals, was related to Kurdistan province (95% CI: 38.9-34.1) (Table 5).
4. DiscussionA data containing 9198 Helicobacter pylori-infected indi-
viduals were included in the current study. A total of 30 papers were entered into the final Meta-analysis. I2 statis-tics showed a high variation among studies results (I2 = 97.4, P = 0.000). In three studies, including those carried out in Gilan, Sari and Qazvin, sampling had been carried out in villages as well as in cities (17, 33, 38). The preva-lence rate of H. pylori was calculated for all the individuals in all the age groups, based on the status of the individu-als, gender and age groups.In our review, random effect models were used for meta-analysis, considering the possibility of significant hetero-geneity between studies which was tested with the Q test. 
Table 2.  Prevalence Rate of H. pylori Infection in Iran According to Different Diagnostic Methods
Diagnostic Methods Study, No. H. pylori, %, 95% CI
Total Recognize group 30 50.7 (44.4-56.9)
ELISA 10 52.3 (43.8-60.8)
Urease test 8 51.9 (36.9-66.9)
Other methods 5 45.8 (31.3-60.4)
Table 3.  Prevalence Rate of H. pylori Infection in Iran According to Health Status, Age and Gender
Study, No. H. pylori, %, 95% CI
Total 30 50.7 (44.4-56.9)
Sex - -Women 5 37.7 (27.5-48)Men 5 35.7 (19.6-51.7)
Population - -Patient 17 47.6 (39.2-56.1)Healthy 13 53.1 (45.4-60.8)
Age, y - 38.3 (28.1-48.5)≤ 20 6 50.3 (39.5-61)20-40 7 60.1 (52.4-67.8)> 40 6 -
Figure 3. H. pylori Prevalence Rate According to the Year of Study and Sample Size
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Table 4.  The Unadjusted and Adjusted Regression Coefficients and Corresponding P Values for Correlation Between Potential Influ-ential Factors and H. pylori Prevalence Using meta-Regression Models
Factors Regression Coefficients P
Year of data collection - -
Unadjusted -0.00332003004 0.707
Adjusted 0.0086586 0.21999
Age group - -
Unadjusted 0.1077322 0.017
Adjusted 0.1222877 0.008
Sample size - -
Unadjusted -0.0001338 0.060
Adjusted -0.000919 0.159
Table 5.  Prevalence Rate of H. pylori in Iran According to City
City Random Effects OR, 95% CI I2, % Sample Size Study, No.
Kashan 48.9 (14.4-2004.3) 93.8 139 2
Sari 41.8 (-0.025-0.86) 99.5 20004 2
Semnan 48 (44.3-51.7) - 700 1
Ghazvin 61.7 (26.6-96.8) 97.4 245 2
Khorasan Razavi 48.6 (21.3-75.9) 96.9 32003 2
Tehran 53.5 (39.1-67.8) 98.4 3295 10
Yazd 43.5 (25.1-61.9) - 28 1
Tabriz 57.9 (45.3-70.5) 86.6 418 4
Kerman 56.9 (52.6-61.2) - 513 1
Kurdistan 36.5 (34.1-38.9) 73 1503 1
Isfahan 36.7 (22.6-50.8) 73.4 170 2
Guilan 45.3 (32-58.6) 97.4 1011 2
- 50.7 (44.4-56.9) - 9198 30
In a study carried out in Sari in 132001, a significant correlation was reported between the prevalence rate of infection and home ownership and the family size (38). In the study by Azevedo et al. the major risk factors that have been emphasized were the socioeconomic indica-tors (15).Among the limitations of the current study, the follow-ing can be mentioned: 1) There was not same method to measure variables and diagnostic tests among all stud-ies as well as, 2) The majority of the studies were carried out in a preselected population (blood donors, individu-als referring to health care centers and etc.). 3) In most studies, nutritional status and life style were not consid-ered as influencing factors. 4) The range of age groups was considerably wide among different studies.This study aimed to determine the prevalence rate of H. pylori infection in Iran. Almost half the population 
in Iran is infected by H. pylori, the prevalence rate being different among different parts of the country. Accord-ing to the findings of this study, it is suggested that, to prevent the spread of H. pylori, comprehensive health programs should be scheduled throughout the country. According to the results of this study, the risk of H. py-lori infection significantly increases with age, and so, it is recommended that preventive procedures are more seriously followed for high risk age groups. It is also rec-ommended that the ELISA and urease tests are used in diagnostic laboratories to increase the accuracy and per-ception of diagnostic methods.Funnel plot (Figure 4) showed the effects of publication bias was significant in this study. Publication bias is very important in randomized clinical trials and case control studies, but it is not important in the meta-analysis that estimates prevalence publication bias.
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Figure 4. Funnel Plot to Assess Publication Bias
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